Search PubMed⌕ Search

Biomedical subjects

H Ragde

Publications and source records attributed to H Ragde.

At least 55 records · Page 3Linked to original sources
PubMed1978

Comparison of arteriography, venography, and pyelography in experimental renal trauma.

Experimentally produced renal injuries are shown by arteriography, venography, and retrograde pyelography using geometric magnification techniques. Arteriography is the most satisfactory modality examined. Venography is technically more difficult and generally less sensitive than arteriography, although extravasation of contrast material was shown with equal frequency. Retrograde pyelography is inferior to arteriography and correlates closely with the venographic findings.

Animals↗
PubMed1969

Hemophilia: role of organ homografts.

The concentration of factor VIII and partial thromboplastin times became normal and have remained normal for 140 days after orthotopic tranplantation of a normal liver to a hemophilic dog. Transplantation of a normal spleen into a hemophilic recipient did not result in a significant increase in factor VIII although the splenic graft was viable for at least 47 days. Transplantation of normal marrow to a lethally irradiated hemophilic dog did not result in an increase in factor VIII during 34 days of observation.

Animals↗
PubMedDate not supplied

Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up.

In recent years, there has been a resurgence of interest in interstitial radiation as a cost-effective and efficient method of treating organ-confined prostate cancer. We describe our 7- and 8-year results with transperineal Iodine-125 and Palladium-103 implantation. A total of 551 consecutive patients were treated. Of these, 320/551 (58%) received implant alone (Group I), and 231/551 (42%)--considered higher risk patients--were also treated with a modest dose (45 Gy) of external beam irradiation (Group II). The median follow-up for Group I was 55 months, and for Group II, 60 months. At 7 years, the actuarial freedom from biochemical failure (prostate-specific antigen (PSA) < or = 1.0 ng/mL) was 80% in Group I patients, and, at 8 years, 65% in Group II patients. Morbidity was minimal if patients had not undergone prior transurethral prostate resections. The results indicate that interstitial radiation is a valid treatment for clinically localized prostate cancer.

Actuarial Analysis↗